Lv21
106 积分 2025-10-09 加入
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
26分钟前
已完结
The relationship between clinical prognostic factors, microvascular density, and tumor-infiltrating lymphocytes with CD47 and SIRPα expression in diffuse large B cell lymphomas
32分钟前
求助中
Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas
43分钟前
已完结
Polatuzumab Vedotin Approved for DLBCL
46分钟前
已完结
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
1小时前
求助中
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
1小时前
已完结
Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors
2小时前
已完结
Autophagy in the physiological endometrium and cancer
19天前
已完结
[TIPE2 inhibits the stemness of lung cancer cells by regulating the phenotypic polarization of tumor-associated macrophages]
20天前
已关闭
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
29天前
已完结
皖公网安备34019202002308
